McKinsey & Company

Putting innovation—and patients—in focus: A conversation with Astellas Pharma CEO Naoki Okamura

The Tokyo-based biopharmaceutical company is accelerating its pipeline by innovating at the intersection of biology, modality, and disease.

By McKinsey & Company

1 min read

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Strategy & Innovation

Related Insights